Literature DB >> 28378937

Aerobic and resistance exercise in systemic sclerosis: State of the art.

Natália Cristina de Oliveira1, Leslie Andrews Portes1, Henrik Pettersson2, Helene Alexanderson3, Carina Boström3.   

Abstract

INTRODUCTION: Patients with systemic sclerosis (SSc) experience reduced exercise capacity and muscle strength compared with healthy subjects. There are also indications of reduced levels of physical activity.
OBJECTIVE: To present the current knowledge of physical exercise in SSc.
RESULTS: Most studies presently available [three case studies, one single subject experimental design, one study comparing patients with healthy controls, one quasi experimental design (pre-post), two clinical trials and two random controlled trials] have included small samples of patients, mostly composed of patients with and without pulmonary involvement. It seems that patients with SSc without pulmonary involvement are able to perform and benefit from aerobic exercises of at least moderate intensity. Exercise tolerance, aerobic capacity, walking distance, muscle strength and muscle function as well as health-related quality of life (HRQL) have been found to be improved after participation in programmes including aerobic exercise and aerobic exercise combined with resistance exercises. Improvements seem to be only partially retained at follow up. Patients with pulmonary involvement may also experience improved muscle strength, physical and aerobic capacity, as well as HRQL following exercise.
CONCLUSIONS: Patients with SSc without pulmonary involvement can be recommended to be as physically active as the general population. Patients with mild pulmonary involvement can be recommended to be physically active by engaging in exercises of moderate intensity and to participate in moderate-load resistance exercises. Health professionals should inform patients with SSc about the importance of physical activity and avoidance of a sedentary lifestyle.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  aerobic exercise; exercise; exercise therapy; rehabilitation; resistance training; systemic sclerosis

Mesh:

Year:  2017        PMID: 28378937     DOI: 10.1002/msc.1185

Source DB:  PubMed          Journal:  Musculoskeletal Care        ISSN: 1478-2189


  10 in total

Review 1.  Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review.

Authors:  Anna-Maria Hoffmann-Vold; Toby M Maher; Edward E Philpot; Ali Ashrafzadeh; Oliver Distler
Journal:  ERJ Open Res       Date:  2021-02-22

Review 2.  Clinical significance and usefulness of rehabilitation for systemic sclerosis.

Authors:  Naoki Mugii; Yasuhito Hamaguchi; Susanna Maddali-Bongi
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

Review 3.  A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.

Authors:  Lesley Ann Saketkoo; Tracy Frech; Cecília Varjú; Robyn Domsic; Jessica Farrell; Jessica K Gordon; Carina Mihai; Nora Sandorfi; Lee Shapiro; Janet Poole; Elizabeth R Volkmann; Monika Lammi; Kendra McAnally; Helene Alexanderson; Henrik Pettersson; Faye Hant; Masataka Kuwana; Ami A Shah; Vanessa Smith; Vivien Hsu; Otylia Kowal-Bielecka; Shervin Assassi; Maurizio Cutolo; Cristiane Kayser; Victoria K Shanmugam; Madelon C Vonk; Kim Fligelstone; Nancy Baldwin; Kerri Connolly; Anneliese Ronnow; Beata Toth; Maureen Suave; Sue Farrington; Elana J Bernstein; Leslie J Crofford; László Czirják; Kelly Jensen; Monique Hinchclif; Marie Hudson; Matthew R Lammi; Jennifer Mansour; Nadia D Morgan; Fabian Mendoza; Mandana Nikpour; John Pauling; Gabriela Riemekasten; Anne-Marie Russell; Mary Beth Scholand; Elise Seigart; Tatiana Sofia Rodriguez-Reyna; Laura Hummers; Ulrich Walker; Virginia Steen
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-09-15       Impact factor: 4.991

4.  Alterations of Lysine Acetylation Profile in Murine Skeletal Muscles Upon Exercise.

Authors:  Dehuan Liang; Cheng Chen; Song Huang; Sujuan Liu; Li Fu; Yanmei Niu
Journal:  Front Aging Neurosci       Date:  2022-05-03       Impact factor: 5.702

5.  High-intensity interval training can improve hand grip strength, inspiratory muscle, and quality of life in systemic sclerosis subjects.

Authors:  Irma Ruslina Defi; Chandrawati Gultom; Maria Jessica Chorman; Jennie Jennie
Journal:  Reumatologia       Date:  2021-04-27

6.  The effects of upper and lower limb exercise on the microvascular reactivity in limited cutaneous systemic sclerosis patients.

Authors:  A Mitropoulos; A Gumber; H Crank; M Akil; M Klonizakis
Journal:  Arthritis Res Ther       Date:  2018-06-05       Impact factor: 5.156

7.  Effect of a tailored home-based exercise program in patients with systemic sclerosis: A randomized controlled trial.

Authors:  Mirko Filippetti; Lucia Cazzoletti; Francesco Zamboni; Pietro Ferrari; Cristian Caimmi; Nicola Smania; Stefano Tardivo; Marcello Ferrari
Journal:  Scand J Med Sci Sports       Date:  2020-05-11       Impact factor: 4.221

8.  Investigating the effectiveness and feasibility of exercise on microvascular reactivity and quality of life in systemic sclerosis patients: study protocol for a feasibility study.

Authors:  Alexandros Mitropoulos; Anil Gumber; Helen Crank; Mohammed Akil; Markos Klonizakis
Journal:  Trials       Date:  2018-11-21       Impact factor: 2.279

Review 9.  The effect and safety of exercise therapy in patients with systemic sclerosis: a systematic review.

Authors:  Sophie I E Liem; Theodora P M Vliet Vlieland; Jan W Schoones; Jeska K de Vries-Bouwstra
Journal:  Rheumatol Adv Pract       Date:  2019-12-09

10.  The Preventive Role of Physical Activity in Systemic Sclerosis: A Cross-Sectional Study on the Correlation with Clinical Parameters and Disease Progression.

Authors:  Cristina Antinozzi; Elisa Grazioli; Maria De Santis; Francesca Motta; Paolo Sgrò; Federico Mari; Caterina Mauri; Attilio Parisi; Daniela Caporossi; Guglielmo Duranti; Roberta Ceci; Luigi Di Luigi; Ivan Dimauro
Journal:  Int J Environ Res Public Health       Date:  2022-08-18       Impact factor: 4.614

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.